Skip to main content
SK bioscience Co.,Ltd. (KRX:302440)
South Korea flag South Korea · Delayed Price · Currency is KRW
40,200
+1,400 (3.61%)
At close: May 8, 2025, 3:30 PM KST

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Vaccine/Biopharmaceuticals
369.51B
Log In
Log In
Log In
Log In
Vaccine/Biopharmaceuticals Growth
-19.10%
Log In
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
America
185.96B
Log In
Log In
Log In
Log In
America Growth
-14.63%
Log In
Log In
Log In
Log In
South Korea
158.22B
Log In
Log In
Log In
Log In
South Korea Growth
-29.42%
Log In
Log In
Log In
Log In
Europe
21.20B
Log In
Log In
Log In
Log In
Europe Growth
53.88%
Log In
Log In
Log In
Log In
Asia
3.89B
Log In
Log In
Log In
Log In
Asia Growth
497.76%
Log In
Log In
Log In
Log In
Middle East
231.61M
Log In
Log In
Log In
Log In
Middle East Growth
-24.07%
Log In
Log In
Log In
Log In